Skip to main content
Veterinary Medicines

ZOLETIL 50 (25 MG/ML + 25 MG/ML) LYOPHILISATE AND SOLVENT FOR SOLUTION FOR INJECTION FOR DOGS AND CATS

Authorised
  • Tiletamine hydrochloride
  • Zolazepam hydrochloride

Product identification

Medicine name:
ZOLETIL 50 (25 MG/ML + 25 MG/ML) LYOPHILISATE AND SOLVENT FOR SOLUTION FOR INJECTION FOR DOGS AND CATS
ZOLETIL 50 (25 MG/ML + 25 MG/ML) LYOPHILISAT ET SOLVANT POUR SOLUTION INJECTABLE POUR CHIENS ET CHATS
Active substance:
  • Tiletamine hydrochloride
  • Zolazepam hydrochloride
Target species:
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Intravenous use

Product details

Active substance and strength:
  • Tiletamine hydrochloride
    145.43
    milligram(s)
    /
    1.00
    Bottle
  • Zolazepam hydrochloride
    140.94
    milligram(s)
    /
    1.00
    Bottle
Pharmaceutical form:
  • Lyophilisate and solvent for solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Dog
    • Cat
  • Intravenous use
    • Dog
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX99
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
  • Virbac
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/7978320 6/2016
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0283/001
Concerned member states:
  • Finland
  • Ireland
  • Netherlands
  • Poland
  • Sweden

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 11/04/2025

Combined File of all Documents

English (PDF)
Published on: 14/03/2025
Download

Package Leaflet and Labelling

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 15/10/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."